# Nonclinical Evaluation of Endocrine-Related Drug Toxicity - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/nonclinical-evaluation-of-endocrine-related-drug-toxicity/3925c81a-41d1-4ab8-a0da-0aec3f634c05

> FDA guidance document: Nonclinical Evaluation of Endocrine-Related Drug Toxicity. Issue date: September 09, 2015. Get complete insights and analysis.

---

## Details

- Title: Nonclinical Evaluation of Endocrine-Related Drug Toxicity
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2015-09-09
- Last Changed: 2020-05-14

## Related Documents

- [Allergic Rhinitis: Developing Drug Products for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/allergic-rhinitis-developing-drug-products-for-treatment-guidance-for-industry/dcca7128-d84a-436f-83a2-e705904c701f)
- [Uncomplicated Gonorrhea: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/uncomplicated-gonorrhea-developing-drugs-for-treatment/56891f77-fa9d-4c61-87e8-d129790d9d35)
- [Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/human-immunodeficiency-virus-1-infection-developing-antiretroviral-drugs-for-treatment/29bfce2d-7907-435c-b6f8-596f490430cb)